Valby

Jacobs and PA Consulting to Provide Consulting Advisory Services to The Copenhagen Metro

Retrieved on: 
Thursday, November 9, 2023

DALLAS, Nov. 9, 2023 /PRNewswire/ -- Jacobs (NYSE:J) and PA Consulting (PA) have been selected by The Copenhagen Metro (Metroselskabet I/S) to be part of its Operations and Maintenance Adviser Framework. The Copenhagen Metro provides fast, sustainable, carbon-efficient transport solutions to more than 300,000 passengers on weekdays.

Key Points: 
  • Framework aids further development of sustainable, connected urban transport solutions
    DALLAS, Nov. 9, 2023 /PRNewswire/ -- Jacobs (NYSE:J) and PA Consulting (PA) have been selected by The Copenhagen Metro (Metroselskabet I/S) to be part of its Operations and Maintenance Adviser Framework.
  • The Copenhagen Metro provides fast, sustainable, carbon-efficient transport solutions to more than 300,000 passengers on weekdays.
  • The Jacobs and PA team was selected to provide comprehensive research and advice on the operation and maintenance of the metro.
  • The Copenhagen Metro is also working on a potential new metro line, M5, that will connect new city development areas to the east of Copenhagen with 10 stations from Copenhagen Central Station to Lynetteholm and Østerport.

Rgenta Therapeutics Enters into a Collaboration with Lundbeck

Retrieved on: 
Wednesday, August 4, 2021

Under the collaboration agreement, Rgenta will use its novel and integrative discovery platform to identify and optimize RNA-targeting small molecules against high-value targets.

Key Points: 
  • Under the collaboration agreement, Rgenta will use its novel and integrative discovery platform to identify and optimize RNA-targeting small molecules against high-value targets.
  • Rgenta will grant Lundbeck the option to exclusively license the candidate molecules, which will be developed and commercialized by Lundbeck.
  • In addition, Rgenta is eligible to receive tiered royalties on global net sales of products resulting from the collaboration.
  • Lundbeck and Rgenta may elect to expand the partnership to include other brain disease targets for additional consideration.

Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science

Retrieved on: 
Monday, August 2, 2021

53 LR

Key Points: 
  • 53 LR
    Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced the appointment of Mikhail Kalinichev, PhD, as Head of Translational Science.
  • He is an accomplished neuropharma researcher and drug developer who already knows Addex and our research programs, said Tim Dyer, CEO of Addex.
  • Dr. Kalinichev joins Addex from Ipsen where he was Director of in vivo neurology.
  • Before Lundbeck, Dr. Kalinichev held various positions at Addex, including Associate Director and Group Leader, Behavioral Neuroscience.

Braxia Scientific to Discuss Psychiatric Treatment Discovery and Development with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021

Retrieved on: 
Wednesday, July 7, 2021

Braxia CEO Dr. Roger McIntyre will engage with Oxford scientists on the question of "How can we advance treatment discovery and development in psychiatry targeting cognition?"

Key Points: 
  • Braxia CEO Dr. Roger McIntyre will engage with Oxford scientists on the question of "How can we advance treatment discovery and development in psychiatry targeting cognition?"
  • Participating companies include: Braxia Scientific, Lundbeck, Compass Pathways, P1vital, Circadian Therapeutics, Zogenix, Cyclica, Precision Life, Beckley Psytech, BrainBerry, Braincures, BrainPatch, Psious, Jazz Pharmaceuticals & Ranvier Health.
  • The medical solutions company aims to reduce the illness burden of brain-based mental disorders such as major depressive disorder among others.
  • The Company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Lundbeck Recognized as One of the Best Companies to Work for in Egypt

Retrieved on: 
Thursday, January 21, 2021

In 2015, we set out to realize a dream; 'To establish Lundbeck Egypt among the best employers in the pharmaceutical industry through a unique culture and working environment'.

Key Points: 
  • In 2015, we set out to realize a dream; 'To establish Lundbeck Egypt among the best employers in the pharmaceutical industry through a unique culture and working environment'.
  • We will continue to strive to make Lundbeck Egypt an even better place to work, so we can continue to make a difference for people living with brain diseases said Ahmed El-Ashmawy, Country Manager for Lundbeck Egypt.
  • "Despite the disruption brought about by the pandemic, the results showed that Lundbeck employees in Egypt feel overwhelmingly positive toward the workplace culture said Hamza Idrissi, Program Manager for Egypt.
  • Best Places To Work is the most definitive Employer of Choice certification that organizations aspire to achieve.

The Carlsberg Foundations Donate DKK 95 Million (approx. $13.8m) to Accelerate Efforts Against COVID-19

Retrieved on: 
Monday, March 23, 2020

The New Carlsberg Foundation, which supports the arts, donates DKK 30 million to restart crisis-affected art museums.

Key Points: 
  • The New Carlsberg Foundation, which supports the arts, donates DKK 30 million to restart crisis-affected art museums.
  • The Carlsberg Foundation is the parent foundation for the Carlsberg family and one of the worlds oldest commercial foundations.
  • In 1902, his son, Carl, and his wife, Ottilia Jacobsen, donated the New Carlsberg Brewery to the Carlsberg Foundation.
  • At the same time, they established the New Carlsberg Foundation as an independent foundation under the Carlsberg Foundation.

Nordisk Film Cinemas selects Selligent Marketing Cloud to drive personalized customer engagements across web, email, mobile and social

SAN JOSE, Calif. and LONDON, March 03, 2020 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent) , the intelligent omnichannel marketing and experience cloud platform, today announced leading Nordic entertainment company, Nordisk Film Cinemas , as a client.

Key Points: 
  • SAN JOSE, Calif. and LONDON, March 03, 2020 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent) , the intelligent omnichannel marketing and experience cloud platform, today announced leading Nordic entertainment company, Nordisk Film Cinemas , as a client.
  • Operator of the largest cinema chain in Denmark and Norway, Nordisk Film Cinemas attracts about 9 million guests each year.
  • Nordisk Film Cinemas web properties ( nfbio.dk , nfkino.no and nfbio.se ) and native apps provide movie enthusiasts with state of the art digital platforms to purchase tickets.
  • Selligent will enable Nordisk Film Cinemas to continue to interact with its strong and growing customer base, with automated and personalized communication that is always relevant.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Alder BioPharmaceuticals, Inc. to H. Lundbeck A/S is Fair to Shareholders

Retrieved on: 
Monday, September 16, 2019

You are hereby notifiedthat Levi & Korsinsky, LLP has commenced aninvestigationinto thefairness of the sale of Alder to H. Lundbeck A/S (Lundbeck).

Key Points: 
  • You are hereby notifiedthat Levi & Korsinsky, LLP has commenced aninvestigationinto thefairness of the sale of Alder to H. Lundbeck A/S (Lundbeck).
  • To learn more about the action and your rights,go to:
    or contact Joseph E. Levi, Esq.
  • either via email at [email protected] or by telephone at (212) 363-7500.There is no cost or obligation to you.
  • Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C.

Azilect, 2019: Global Drug Overview, Product Profiles, Parkinson's Disease - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 18, 2019

Azilect prolongs the activity of dopamine in the brain to restore a measure of normal locomotion, gait, and coordination.

Key Points: 
  • Azilect prolongs the activity of dopamine in the brain to restore a measure of normal locomotion, gait, and coordination.
  • In June 2014, the drug was approved in the US as an adjunct to dopamine.
  • Azilect is marketed by Teva and Lundbeck, with the partnership providing Lundbeck a license spanning Europe and certain Asian countries.
  • Lundbeck transferred sales rights in Europe back to Teva during 2016 upon the availability of the first generics.

LIONSGATE AND NORDISK FILM ANNOUNCE NEW MULTI-YEAR OUTPUT DEAL IN SCANDINAVIA

Retrieved on: 
Wednesday, August 15, 2018

SANTA MONICA,Calif.and COPENHAGEN, Denmark, Aug. 15, 2018 /PRNewswire/ -- Global content leader Lionsgate (NYSE: LGF.A, LGF.B) has entered a new multiyear output deal with longstanding partner Nordisk Film in Scandinavia, the two companies announced today.

Key Points: 
  • SANTA MONICA,Calif.and COPENHAGEN, Denmark, Aug. 15, 2018 /PRNewswire/ -- Global content leader Lionsgate (NYSE: LGF.A, LGF.B) has entered a new multiyear output deal with longstanding partner Nordisk Film in Scandinavia, the two companies announced today.
  • "Together with our continuously growing local product portfolio, the deal with Lionsgate will constitute the backbone of Nordisk Film's leading market position in Scandinavia."
  • Peter Philipsen, General Manager International Acquisitions & Distribution, and Christopher Seidelin, Head of International Acquisitions, negotiated the agreement on behalf of Nordisk Film.
  • Nordisk Film is part of Egmont a leading media group in the Nordics with 6,600 employees and activities in 30 countries.